The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Recombinant human activated FVII as prophylaxis in surgical treatment of cancer patient with acquired hemophilia A.
Giacinto La Verde
No relevant relationships to disclose
Antonella Ferrari
No relevant relationships to disclose
Vincenzo Ziparo
No relevant relationships to disclose
Virginia Naso
No relevant relationships to disclose
Maria Paola Bianchi
No relevant relationships to disclose
Giusy Antolino
No relevant relationships to disclose
Francesca Saltarelli
No relevant relationships to disclose
Bruno Monarca
No relevant relationships to disclose
Federica Resci
No relevant relationships to disclose
Daniela De Benedittis
No relevant relationships to disclose
Alessandro Moscetti
No relevant relationships to disclose